Blar i forfatter "Murchan, Stephen"

Viser treff 1-2 av 2

    • Staphylococcus aureus bloodstream infections: Diverging trends of meticillin-resistant and meticillin-susceptible isolates, EU/EEA, 2005 to 2018 

      Gagliotti, Carlo; Högberg, Liselotte Diaz; Billström, Hanna; Eckmanns, Tim; Giske, Christian G.; Heuer, Ole E.; Jarlier, Vincent; Kahlmeter, Gunnar; Wong, Danilo Lo Fo; Monen, Jos; Murchan, Stephen; Simonsen, Gunnar Skov; Šubelj, Maja; Andrašević, Arjana Tambić; Żabicka, Dorota; Žemličková, Helena; Monnet, Dominique L. (Journal article; Tidsskriftartikkel; Peer reviewed, 2021-11-18)
      Background: Invasive infections caused by Staphylococcus aureus have high clinical and epidemiological relevance. It is therefore important to monitor the S. aureus trends using suitable methods. Aim: The study aimed to describe the trends of bloodstream infections (BSI) caused by meticillin-resistant S. aureus (MRSA) and meticillin-susceptible S. aureus (MSSA) in the European Union (EU) and the ...

    • Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: towards a common nomenclature 

      Bender, Jennifer; Cattoir, Vincent; Hegstad, Kristin; Sadowy, Eva; Coque, Teresa M.; Westh, Henrik; Hammerum, Anette M.; Schaffer, Kirsten; Burns, Karen; Murchan, Stephen; Novais, Carla; Freitas, Ana R.; Peixe, Luísa; Del Grosso, Maria; Pantosti, Annalisa; Werner, Guido (Journal article; Tidsskriftartikkel; Peer reviewed, 2018-11-02)
      Vancomycin-resistant enterococci (VRE) are important nosocomial pathogens. Invasive VRE infections are difficult to treat since common therapeutic options including ampicillin and glycopeptides often fail. In vitro, most VRE remain susceptible to last-resort antibiotics such as linezolid, tigecycline and daptomycin. However, neither tigecycline nor linezolid act in a bactericidal manner, and ...